STUART S LEICHT

Allopathic & Osteopathic Physicians|Dermatology JOHNSON CITY, TN NPI 1013902907

General Payments — all program years on this page

$1,464.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $363.40 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $294.4117
Education $68.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $13.141
2019 $41.333
2020 $174.869
2021 $385.6020
2022 $255.5214
2023 $230.729
2024 $363.4018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087021638 Novartis Pharmaceuticals Corporation $26.07 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021644 Novartis Pharmaceuticals Corporation $23.98 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021674 Novartis Pharmaceuticals Corporation $25.71 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101392282 E.R. Squibb & Sons, L.L.C. $21.60 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101392292 E.R. Squibb & Sons, L.L.C. $22.76 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101392308 E.R. Squibb & Sons, L.L.C. $14.09 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101392366 E.R. Squibb & Sons, L.L.C. $25.32 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135418227 Lilly USA, LLC $21.32 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135429311 Lilly USA, LLC $21.58 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205601 SUN PHARMACEUTICAL INDUSTRIES INC. $68.99 02/20/2024 Education Undisputed 01/23/2026 View at CMS
1152205603 SUN PHARMACEUTICAL INDUSTRIES INC. $17.03 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205605 SUN PHARMACEUTICAL INDUSTRIES INC. $15.71 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205607 SUN PHARMACEUTICAL INDUSTRIES INC. $1.58 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205609 SUN PHARMACEUTICAL INDUSTRIES INC. $19.48 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205611 SUN PHARMACEUTICAL INDUSTRIES INC. $7.97 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205613 SUN PHARMACEUTICAL INDUSTRIES INC. $16.82 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205615 SUN PHARMACEUTICAL INDUSTRIES INC. $7.37 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152205617 SUN PHARMACEUTICAL INDUSTRIES INC. $6.02 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.